Weekend Edition Saturday
<iframe src="http://www.npr.org/player/embed/4234877/4234878" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Earlier this year the government announced plans to buy enough anthrax vaccine to cover 25 million Americans. But a new study suggests that in many scenarios, a vaccine is unlikely to save many lives. NPR's David Kestenbaum reports.
NPR thanks our sponsors
Become an NPR sponsor